A phase I study to investigate the absorption, metabolism and excretion of [14C]-bilastine following oral administration to healthy volunteers.

Trial Profile

A phase I study to investigate the absorption, metabolism and excretion of [14C]-bilastine following oral administration to healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Sep 2012

At a glance

  • Drugs Bilastine (Primary)
  • Indications Allergic conjunctivitis; Perennial allergic rhinitis; Seasonal allergic rhinitis; Urticaria
  • Focus Pharmacokinetics
  • Sponsors FAES Farma
  • Most Recent Events

    • 09 Jan 2009 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
    • 09 Jan 2009 Actual start date changed from Dec 2007 to Nov 2007 as reported by ClinicalTrials.gov.
    • 09 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top